feed,title,long_url,short_url
TheStreet,Ocular Therapeutix Stock Slumps; Dry-Eye Drug Misses Trial Endpoint HOLD,https://www.thestreet.com/investing/ocular-therapeutix-shares-slump-dry-eye-drug-misses-endpoint,https://j.mp/3C6ZMhv
